Bacteria in Yogurt Modified to Fight HIV Infection
Get the world’s most fascinating discoveries delivered straight to your inbox.
You are now subscribed
Your newsletter sign-up was successful
Want to add more newsletters?
Delivered Daily
Daily Newsletter
Sign up for the latest discoveries, groundbreaking research and fascinating breakthroughs that impact you and the wider world direct to your inbox.
Once a week
Life's Little Mysteries
Feed your curiosity with an exclusive mystery every week, solved with science and delivered direct to your inbox before it's seen anywhere else.
Once a week
How It Works
Sign up to our free science & technology newsletter for your weekly fix of fascinating articles, quick quizzes, amazing images, and more
Delivered daily
Space.com Newsletter
Breaking space news, the latest updates on rocket launches, skywatching events and more!
Once a month
Watch This Space
Sign up to our monthly entertainment newsletter to keep up with all our coverage of the latest sci-fi and space movies, tv shows, games and books.
Once a week
Night Sky This Week
Discover this week's must-see night sky events, moon phases, and stunning astrophotos. Sign up for our skywatching newsletter and explore the universe with us!
Join the club
Get full access to premium articles, exclusive features and a growing list of member rewards.
Bacteria in yogurt have been modified to deliver a drug that blocks HIV infection.
In their natural state, the bacteria (Lactococcus lactis) produce lactic acid and are used to make cheese and yogurt. It is not harmful to humans.
Research based at Brown Medical School in Rhode Island altered the genetics of the bacteria so they generate cyanovirin, a drug that has prevented HIV infection in monkeys and human cells, according to a report at news@nature.com.
Cyanovirin binds to sugar molecules that are attached to the HIV virus, blocking a receptor used by HIV to infect cells.
"It's basically passive immunization," said Sean Hanniffy, a member of the research team from the Institute of Food Research in Norwich, UK.
Cyanovirin could be put into gels that women would apply to the vagina before sex. Or, an oral dose might provide long-term protection, the researchers speculate. They note that there could be public resistance to the whole idea of genetic modification.
The work has only been proved in a lab setting, however. Human trials could begin in 2007.
Get the world’s most fascinating discoveries delivered straight to your inbox.

